staar surgical - STAA

STAA

Close Chg Chg %
17.89 0.45 2.52%

Closed Market

18.34

+0.45 (2.52%)

Volume: 1.17M

Last Updated:

Mar 30, 2026, 4:00 PM EDT

Company Overview: staar surgical - STAA

STAA Key Data

Open

$17.92

Day Range

17.50 - 18.48

52 Week Range

14.69 - 30.81

Market Cap

$885.78M

Shares Outstanding

49.51M

Public Float

49.17M

Beta

1.05

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.63

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.33M

 

STAA Performance

1 Week
 
2.52%
 
1 Month
 
-7.84%
 
3 Months
 
-20.57%
 
1 Year
 
3.09%
 
5 Years
 
-82.66%
 

STAA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About staar surgical - STAA

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

STAA At a Glance

STAAR Surgical Co.
25510 Commercentre Drive
Lake Forest, California 92630
Phone 1-626-303-7902 Revenue 239.44M
Industry Medical Specialties Net Income -80,448,000.00
Sector Health Technology Employees 957
Fiscal Year-end 12 / 2026
View SEC Filings

STAA Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 4.886
Price to Book Ratio 3.387
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -27.45
Enterprise Value to Sales 4.263
Total Debt to Enterprise Value 0.038

STAA Efficiency

Revenue/Employee 250,200.627
Income Per Employee -84,062.696
Receivables Turnover 4.385
Total Asset Turnover 0.493

STAA Liquidity

Current Ratio 4.548
Quick Ratio 3.738
Cash Ratio 2.738

STAA Profitability

Gross Margin 73.879
Operating Margin -19.158
Pretax Margin -34.356
Net Margin -33.598
Return on Assets -16.568
Return on Equity -21.698
Return on Total Capital -21.03
Return on Invested Capital -19.893

STAA Capital Structure

Total Debt to Total Equity 11.143
Total Debt to Total Capital 10.026
Total Debt to Total Assets 8.308
Long-Term Debt to Equity 9.437
Long-Term Debt to Total Capital 8.491
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Staar Surgical - STAA

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
284.39M 322.42M 313.90M 239.44M
Sales Growth
+23.40% +13.37% -2.64% -23.72%
Cost of Goods Sold (COGS) incl D&A
61.01M 69.76M 78.55M 62.55M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.51M 5.12M 6.89M 8.69M
Depreciation
4.48M 5.11M 6.89M 8.28M
Amortization of Intangibles
- 28.00K 13.00K 409.00K
COGS Growth
+17.70% +14.35% +12.59% -20.37%
Gross Income
223.38M 252.65M 235.36M 176.90M
Gross Income Growth
+25.05% +13.10% -6.85% -24.84%
Gross Profit Margin
+78.55% +78.36% +74.98% +73.88%
2022 2023 2024 2025 5-year trend
SG&A Expense
179.64M 224.72M 247.98M 222.84M
Research & Development
35.98M 44.40M 53.29M 39.28M
Other SG&A
143.65M 180.32M 194.69M 183.56M
SGA Growth
+23.63% +25.10% +10.35% -10.14%
Other Operating Expense
(55.00K) (171.00K) (9.00K) (71.00K)
Unusual Expense
- - - 45.77M
-
EBIT after Unusual Expense
43.80M 28.10M (12.61M) (91.64M)
Non Operating Income/Expense
1.75M 5.60M 3.56M 9.38M
Non-Operating Interest Income
2.45M 6.99M 5.91M 4.59M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
45.55M 33.70M (9.05M) (82.26M)
Pretax Income Growth
+45.51% -26.03% -126.86% -808.78%
Pretax Margin
+16.02% +10.45% -2.88% -34.36%
Income Tax
6.80M 12.35M 11.16M (1.81M)
Income Tax - Current - Domestic
- - 27.00K 22.00K
-
Income Tax - Current - Foreign
8.14M 9.09M 7.54M 1.08M
Income Tax - Deferred - Domestic
- (829.00K) 3.32M 3.88M
Income Tax - Deferred - Foreign
(515.00K) (54.00K) (285.00K) (2.92M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
38.76M 21.35M (20.21M) (80.45M)
Minority Interest Expense
- - - -
-
Net Income
38.76M 21.35M (20.21M) (80.45M)
Net Income Growth
+58.18% -44.92% -194.66% -298.10%
Net Margin Growth
+13.63% +6.62% -6.44% -33.60%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
38.76M 21.35M (20.21M) (80.45M)
Preferred Dividends
- - - -
-
Net Income Available to Common
38.76M 21.35M (20.21M) (80.45M)
EPS (Basic)
0.8076 0.4399 -0.4114 -1.623
EPS (Basic) Growth
+55.61% -45.53% -193.52% -294.51%
Basic Shares Outstanding
47.99M 48.52M 49.13M 49.57M
EPS (Diluted)
0.7848 0.4319 -0.4114 -1.623
EPS (Diluted) Growth
+58.42% -44.97% -195.25% -294.51%
Diluted Shares Outstanding
49.38M 49.43M 49.13M 49.57M
EBITDA
48.31M 33.22M (5.72M) (37.18M)
EBITDA Growth
+30.64% -31.24% -117.22% -550.02%
EBITDA Margin
+16.99% +10.30% -1.82% -15.53%

Snapshot

Average Recommendation HOLD Average Target Price 19.722
Number of Ratings 11 Current Quarters Estimate 0.192
FY Report Date 06 / 2026 Current Year's Estimate 0.409
Last Quarter’s Earnings 0.08 Median PE on CY Estimate N/A
Year Ago Earnings -1.00 Next Fiscal Year Estimate 0.652
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 9 8
Mean Estimate 0.19 0.17 0.41 0.65
High Estimates 0.27 0.22 0.75 1.09
Low Estimate 0.13 0.12 -0.17 -0.01
Coefficient of Variance 27.00 26.94 72.11 50.94

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 0 0
OVERWEIGHT 0 0 0
HOLD 10 11 7
UNDERWEIGHT 0 0 0
SELL 0 1 0
MEAN Hold Hold Hold

Insider Actions for Staar Surgical - STAA

Date Name Shares Transaction Value
Apr 8, 2025 Broadwood Capital, Inc. 12,696,579 Open market or private purchase of non-derivative security Non-derivative transaction at $16.97 per share 215,460,945.63
Apr 8, 2025 Broadwood Capital, Inc. 12,696,579 Open market or private purchase of non-derivative security 0.00
Apr 8, 2025 Broadwood Capital, Inc. 13,189,210 Open market or private purchase of non-derivative security Non-derivative transaction at $15.9 per share 209,708,439.00
Apr 8, 2025 Broadwood Capital, Inc. 13,189,210 Open market or private purchase of non-derivative security 0.00
Apr 8, 2025 Broadwood Capital, Inc. 13,194,210 Open market or private purchase of non-derivative security Non-derivative transaction at $16.46 per share 217,176,696.60
Apr 8, 2025 Broadwood Capital, Inc. 13,194,210 Open market or private purchase of non-derivative security 0.00
Apr 8, 2025 Broadwood Capital, Inc. 13,320,675 Open market or private purchase of non-derivative security Non-derivative transaction at $15.58 per share 207,536,116.50
Apr 8, 2025 Broadwood Capital, Inc. 13,320,675 Open market or private purchase of non-derivative security 0.00
Apr 8, 2025 Broadwood Capital, Inc. 13,332,264 Open market or private purchase of non-derivative security Non-derivative transaction at $15.98 per share 213,049,578.72
Apr 8, 2025 Broadwood Capital, Inc. 13,332,264 Open market or private purchase of non-derivative security 0.00

Staar Surgical in the News